| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |